Fulcrum Therapeutics, Inc.

Historical 13F Holders

Symbol
FULC
CUSIP
359616109
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 359616109 since 12/18/2024, largest first.

Filer % of Class Filed
Tang Capital Management LLC 13G/A
10.4% 7/15/2026
Event 7/13/2026
EcoR1 Capital, LLC 13G
9.0% 6/25/2026
Event 6/17/2026
Nantahala Capital Management, LLC 13G
8.2% 8/14/2026
Event 6/30/2026
BlackRock, Inc. 13G/A 7.2% 7/28/2026
Event 6/30/2026
Bank of America Corp /DE/ 13G 6.7% 8/3/2026
Event 6/30/2026
BlackRock Portfolio Management LLC 13G 6.0% 7/17/2026
Event 6/30/2026
Montanova Capital, LLC 13G/A
5.5% 8/14/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
Adage Capital Management, L.P. 13G/A
4.5% 11/13/2025
Event 9/30/2025
RA Capital Management, L.P. 13G/A
0% 8/14/2026
Event 6/30/2026
TCG Crossover GP II, LLC 13G/A
0% 8/14/2026
Event 6/30/2026
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 4 22.5 k $83.1 k
2026 Q2 165 85.8 M $315 M
2026 Q1 176 71.7 M $550 M
2025 Q4 182 67.6 M $764 M
2025 Q3 135 53.8 M $496 M
2025 Q2 132 55.6 M $383 M
2025 Q1 122 51.4 M $148 M
2024 Q4 133 52.0 M $244 M
2024 Q3 155 55.1 M $197 M
2024 Q2 140 66.1 M $410 M
2024 Q1 141 62.9 M $593 M
2023 Q4 110 63.2 M $427 M
2023 Q3 88 56.6 M $251 M
2023 Q2 94 55.5 M $183 M
2023 Q1 123 60.4 M $172 M
2022 Q4 118 51.5 M $374 M
2022 Q3 114 52.2 M $422 M
2022 Q2 113 40.1 M $197 M
2022 Q1 116 39.5 M $930 M
2021 Q4 123 37.5 M $662 M
2021 Q3 111 36.6 M $1.03 B
2021 Q2 69 27.1 M $284 M
2021 Q1 69 26.9 M $317 M
2020 Q4 67 22.2 M $260 M
2020 Q3 56 20.6 M $163 M
2020 Q2 62 20.5 M $374 M
2020 Q1 50 16.8 M $201 M
2019 Q4 40 15.8 M $263 M
2019 Q3 41 16.8 M $110 M